John A. Hansen

34.3k total citations · 6 hit papers
386 papers, 24.6k citations indexed

About

John A. Hansen is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, John A. Hansen has authored 386 papers receiving a total of 24.6k indexed citations (citations by other indexed papers that have themselves been cited), including 234 papers in Immunology, 184 papers in Hematology and 51 papers in Oncology. Recurrent topics in John A. Hansen's work include T-cell and B-cell Immunology (175 papers), Hematopoietic Stem Cell Transplantation (170 papers) and Immune Cell Function and Interaction (113 papers). John A. Hansen is often cited by papers focused on T-cell and B-cell Immunology (175 papers), Hematopoietic Stem Cell Transplantation (170 papers) and Immune Cell Function and Interaction (113 papers). John A. Hansen collaborates with scholars based in United States, South Africa and United Kingdom. John A. Hansen's co-authors include Paul J. Martin, Effie W. Petersdorf, Claudio Anasetti, Rainer Storb, Jean E. Sanders, Eric Mickelson, Bo Dupont, Frederick R. Appelbaum, Anajane G. Smith and Barry E. Storer and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

John A. Hansen

381 papers receiving 23.5k citations

Hit Papers

Analysis of 462 Transplantations from Unrelated Donors Fa... 1985 2026 1998 2012 1993 1985 1991 2005 1990 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Hansen United States 80 13.2k 11.8k 3.7k 2.4k 2.3k 386 24.6k
Claudio Anasetti United States 89 11.9k 0.9× 20.3k 1.7× 5.5k 1.5× 4.7k 1.9× 3.6k 1.5× 459 27.7k
Jerome Ritz United States 103 19.0k 1.4× 12.9k 1.1× 10.1k 2.7× 3.1k 1.3× 4.8k 2.1× 610 36.4k
Robert Peter Gale United States 78 5.3k 0.4× 14.5k 1.2× 5.6k 1.5× 3.9k 1.6× 5.6k 2.4× 609 24.0k
Jacques J. M. van Dongen Netherlands 86 9.4k 0.7× 10.7k 0.9× 4.9k 1.3× 8.2k 3.4× 4.8k 2.0× 504 28.0k
Lee M. Nadler United States 79 14.5k 1.1× 3.6k 0.3× 6.5k 1.7× 1.3k 0.6× 2.7k 1.1× 268 24.6k
Jeffrey S. Miller United States 96 21.4k 1.6× 9.4k 0.8× 11.8k 3.2× 1.2k 0.5× 2.1k 0.9× 607 32.9k
Paul I. Terasaki United States 88 13.3k 1.0× 3.8k 0.3× 1.8k 0.5× 4.3k 1.8× 797 0.3× 620 34.9k
B. Paul Morgan United Kingdom 88 15.0k 1.1× 3.5k 0.3× 1.4k 0.4× 1.4k 0.6× 1.4k 0.6× 620 28.1k
Neal S. Young United States 99 10.1k 0.8× 16.1k 1.4× 3.7k 1.0× 1.3k 0.5× 5.7k 2.4× 598 35.0k
Keith M. Sullivan United States 66 4.6k 0.3× 11.0k 0.9× 3.9k 1.0× 2.7k 1.1× 3.0k 1.3× 241 16.5k

Countries citing papers authored by John A. Hansen

Since Specialization
Citations

This map shows the geographic impact of John A. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Hansen more than expected).

Fields of papers citing papers by John A. Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Hansen. The network helps show where John A. Hansen may publish in the future.

Co-authorship network of co-authors of John A. Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Hansen. A scholar is included among the top collaborators of John A. Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Hansen. John A. Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Paul J., David Levine, Barry E. Storer, et al.. (2022). Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation. Blood Advances. 6(8). 2608–2617. 5 indexed citations
2.
Casto, Amanda M., Sachiko Seo, David Levine, et al.. (2021). Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation. Blood. 138(17). 1628–1636. 5 indexed citations
3.
Martin, Paul J., Barry E. Storer, David Levine, & John A. Hansen. (2021). Genetic variants associated with inflammatory bowel disease and gut graft-versus-host disease. Blood Advances. 5(21). 4456–4464. 3 indexed citations
4.
Reshef, Ran, Wael Saber, Javier Bolaños‐Meade, et al.. (2021). Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study. Journal of Clinical Oncology. 39(17). 1878–1887. 15 indexed citations
5.
Martin, Paul J., David Levine, Barry E. Storer, et al.. (2020). Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantation. Blood Advances. 4(14). 3224–3233. 17 indexed citations
6.
Martin, Paul J., David Levine, Barry E. Storer, et al.. (2016). Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease. Blood. 129(6). 791–798. 76 indexed citations
7.
Inamoto, Yoshihiro, Paul J. Martin, Mary E.D. Flowers, et al.. (2016). Genetic risk factors for sclerotic graft-versus-host disease. Blood. 128(11). 1516–1524. 9 indexed citations
8.
Cooke, Kenneth R., Leo Luznik, Stefanie Sarantopoulos, et al.. (2016). The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 23(2). 211–234. 283 indexed citations breakdown →
9.
Yu, Jeffrey, Barry E. Storer, Kushi Kushekhar, et al.. (2016). Biomarker Panel for Chronic Graft-Versus-Host Disease. Journal of Clinical Oncology. 34(22). 2583–2590. 89 indexed citations
10.
Leger, Kasey J., Kara L. Cushing‐Haugen, John A. Hansen, et al.. (2016). Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors. Biology of Blood and Marrow Transplantation. 22(6). 1094–1101. 33 indexed citations
11.
Hahn, Theresa, Lara E. Sucheston‐Campbell, Leah Preus, et al.. (2015). Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(9). 1679–1686. 16 indexed citations
12.
Paczesny, Sophie, Frances T. Hakim, Joseph Pidala, et al.. (2015). National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: III. The 2014 Biomarker Working Group Report. PMC. 1 indexed citations
13.
Petersdorf, Effie W. & John A. Hansen. (2008). New advances in hematopoietic cell transplantation. Current Opinion in Hematology. 15(6). 549–554. 17 indexed citations
14.
Waldorf, Kristina M. Adams, et al.. (2004). Adverse outcomes after preterm labor are associated with tumor necrosis factor-α polymorphism −863, but not −308, in mother-infant pairs. American Journal of Obstetrics and Gynecology. 191(4). 1362–1367. 37 indexed citations
15.
Petersdorf, E.W., Claudio Anasetti, Paul J. Martin, & John A. Hansen. (2003). Tissue typing in support of unrelated hematopoietic cell transplantation. Tissue Antigens. 61(1). 1–11. 47 indexed citations
16.
Doney, K, Rainer Storb, Frederick R. Appelbaum, et al.. (1993). Recombinant granulocyte‐macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia. British Journal of Haematology. 85(1). 182–184. 5 indexed citations
17.
Hansen, John A.. (1992). Innovation, firm size, and firm age. Small Business Economics. 4(1). 37–44. 217 indexed citations
18.
Anasetti, Claudio, Philip Tan, John A. Hansen, & Paul J. Martin. (1990). Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen.. The Journal of Experimental Medicine. 172(6). 1691–1700. 39 indexed citations
19.
Nepom, Gerald T., Barbara S. Nepom, Paolo Antonelli, et al.. (1984). The HLA-DR4 family of haplotypes consists of series of distinct DR and DS molecules.. The Journal of Experimental Medicine. 159(2). 394–404. 67 indexed citations
20.
Mauseth, Richard, John A. Hansen, Elizabeth K. Smith, Eloise R. Giblett, & Vincent C. Kelley. (1980). Detection of heterozygotes for congenital adrenal hyperplasia: 21-Hydroxylase deficiency—a comparison of HLA typing and 17-OH progesterone response to ACTH infusion. The Journal of Pediatrics. 97(5). 749–753. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026